Open AccessPB2023: UPDATE AND FOLLOW‐UP OF NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) WITH HIGH‐RISK CYTOGENETIC (HRC).
Author(s) -
Nuevo López M. I.,
Merchan Muñoz B.,
Marta M. A.,
Rocio P. A.,
angela G. P.,
Helga G. G.,
Dunia D. M. L.,
Nuria G.,
alejandro V. R.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850924.02136.49
Subject(s) - medicine , multiple myeloma , cohort , plasma cell leukemia , retrospective cohort study , oncology , monoclonal gammopathy of undetermined significance , overall survival , clinical significance , surgery , immunology , monoclonal , antibody , monoclonal antibody